Check-Cap (NASDAQ:MBAI) Trading Down 0.7% – Here’s What Happened

Shares of Check-Cap Ltd (NASDAQ:MBAI) were down 0.7% during trading on Thursday . The stock traded as low as $8.33 and last traded at $8.83. Approximately 57,301 shares changed hands during mid-day trading, a decline of 37% from the average session volume of 91,578 shares. The stock had previously closed at $8.89.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Check-Cap in a report on Tuesday, July 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Check-Cap has an average rating of “Sell”.

Check-Cap Stock Performance

The firm has a market cap of $11.79 million, a price-to-earnings ratio of -4.34 and a beta of 0.68. The business’s 50 day moving average price is $8.51 and its 200 day moving average price is $10.68.

About Check-Cap

Check-Cap Ltd. (NASDAQ: MBAI) is an Israel-based medical technology company focused on non-invasive screening solutions for colorectal cancer. The company develops an ingestible imaging capsule and associated detection system intended to provide a patient-friendly alternative to traditional colonoscopy and CT colonography for colorectal screening and polyp detection.

Check-Cap’s technology centers on a swallowable capsule that acquires images of the colon as it traverses the gastrointestinal tract; external detectors capture the transmitted signals and software reconstructs images for clinical review.